Hakkında
Dr Alzouebi is a Consultant Clinical Oncologist at Weston Park Hospital, specialising in the treatment of cancers of the urinary tract, particularly prostate, kidney, and bladder cancer. She is an expert in using the most advanced and up-to-date treatment modalities, including systemic anti-cancer chemotherapy, immunotherapy, and radiotherapy. Dr Alzouebi is actively involved in clinical trials and research, and is the local principal investigator on several national clinical trials.
She completed her general medical training in the Yorkshire Deanery, achieving MRCP and DTMH qualifications, and completed the Clinical Oncology Training Programme at Weston Park Hospital in Sheffield. She obtained a Distinction in a Master’s Degree in Oncology from the University of Nottingham and her dissertation research was published in a peer-reviewed journal. Dr Alzouebi holds a substantive NHS post as a Consultant Clinical Oncologist at Sheffield Teaching Hospital NHS Foundation Trust.
Her treatments include Systemic Drug Therapy/Chemotherapy (Novel Targeted Anticancer Drug Treatment, Systemic Chemotherapy, Immunotherapy, Monoclonal Antibodies, Endocrine Therapy, Radium-223, and Tyrosine Kinase therapy) and Radiotherapy (Intensity Modulated Radiotherapy, Image Guided Radiotherapy, Adaptive Radiotherapy, Stereotactic Ablative Radiotherapy, and SABR). Her areas of interest include Advanced Radiotherapy Techniques for Prostate and Bladder Cancer, Prostate SABR, and Chemotherapy in Prostate, Kidney, and Bladder Cancer. Dr Alzouebi also works in partnership with Genesiscare to offer SpaceOAR for prostate radiotherapy.
She completed her general medical training in the Yorkshire Deanery, achieving MRCP and DTMH qualifications, and completed the Clinical Oncology Training Programme at Weston Park Hospital in Sheffield. She obtained a Distinction in a Master’s Degree in Oncology from the University of Nottingham and her dissertation research was published in a peer-reviewed journal. Dr Alzouebi holds a substantive NHS post as a Consultant Clinical Oncologist at Sheffield Teaching Hospital NHS Foundation Trust.
Her treatments include Systemic Drug Therapy/Chemotherapy (Novel Targeted Anticancer Drug Treatment, Systemic Chemotherapy, Immunotherapy, Monoclonal Antibodies, Endocrine Therapy, Radium-223, and Tyrosine Kinase therapy) and Radiotherapy (Intensity Modulated Radiotherapy, Image Guided Radiotherapy, Adaptive Radiotherapy, Stereotactic Ablative Radiotherapy, and SABR). Her areas of interest include Advanced Radiotherapy Techniques for Prostate and Bladder Cancer, Prostate SABR, and Chemotherapy in Prostate, Kidney, and Bladder Cancer. Dr Alzouebi also works in partnership with Genesiscare to offer SpaceOAR for prostate radiotherapy.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Mymoona Alzouebi
Eğitim ve öğretim
-
2005–2011 MD · Medicine and Surgery
-
2011–2015 Residency · Onkoloji
Kariyer ve atamalar
-
2015-09–2016-08 Junior consultant
Lisanslar ve sigorta
Tıbbi lisanslar
GB — Organización Médica Colegial de España (OMC)
Kurul sertifikaları
European Board of Onkoloji
Mesleki sorumluluk sigortası:
AXA Healthcare Liability · 1,000,000 EUR kapsam · No claims on file
Gerçekleştirilen prosedürler
| Prosedür | Kod | Toplam sayı |
|---|---|---|
| GP consultation | 99213 | 1,819 |
| Annual physical exam | 99395 | 1,237 |
| Vaccination administration | 90471 | 1,053 |
| Minor procedure (skin) | 17110 | 586 |
Hizmetler ve fiyatlandırma
| Hizmet | Süre | Yöntem | Fiyat |
|---|---|---|---|
| New patient consultation (60m) | 60 dk | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 dk | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 dk | in_clinic | 360.00 EUR |
| Minor procedure (skin) | 60 dk | in_clinic | 270.00 EUR |
Ofis, ekip ve uygulamada
Videolar
Araştırma ve yayınlar
h-endeksi: 15 · i10: 15
-
Long-term follow-up of Onkoloji across GB
DOI: 10.9711/euroclin.2026.0 · PMID: 36234510 · alıntılayan 187
-
Validation of clinical scoring in Onkoloji
DOI: 10.9456/euroclin.2025.1 · PMID: 31706029 · alıntılayan 81
-
Long-term follow-up of Onkoloji across GB
DOI: 10.9648/euroclin.2024.2 · PMID: 36028681 · alıntılayan 39
-
Validation of clinical scoring in Onkoloji
DOI: 10.3301/euroclin.2023.3 · PMID: 37363220 · alıntılayan 37
Davetli konuşmalar
- Practical updates in Onkoloji European Annual Congress (Onkoloji) · Vienna · 2024 · invited
- Single-centre experience in Onkoloji National Society Meeting · Sheffield · 2023 · oral abstract
Ödüller ve üyelikler
Ödüller
- 🏆 Top-rated Onkoloji — Sheffield · EuroClinics Patient Choice · 2025 · regional
Topluluk üyelikleri
- WONCA Europe — Family Doctors — Member · 2016 yılından beri
- national college of family doctors — Member · 2016 yılından beri
- European Union of Medical Specialists (UEMS) — Member · 2016 yılından beri
Bu doktorun makaleleri
- Patient education Patient guide to Onkoloji
- Awareness When should you see a onkoloji?
Uluslararası hastalar için
- Koordinatör
- Patient liaison · dr.mymoona.alzouebi@euroclinics.example
Konum
1 etiketHasta yorumları
Deneyiminizi paylaşın — diğer hastaların doğru doktoru bulmasına yardımcı olun. Yorum yaz →
Son yorumlar
-
★★★★★ ✓ Doğrulanmış Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Doğrulanmış Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Doğrulanmış Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
